Concepedia

Shruti Agrawal

SA

Statistics

Publications

10

Citations

13.6K

H-Index

10

Active since

2006

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Dana-Farber Cancer Institute

Yale Cancer Center

Shruti Agrawal is an author at Bristol-Myers Squibb (Germany) specializing in oncology, pharmacology, and cancer immunotherapy.

ORCID

Publications per year

2006–2023

10

Publications

10

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text

, , +17

Adoption of green finance and green innovation for achieving circularity: An exploratory review and future directions

Rohit Agrawal, Shruti Agrawal, Ashutosh Samadhiya et al. · Geoscience Frontiers · 2023 · 355 citations · Full text

, , +17

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Shruti Agrawal, Feng Yan, Amit Roy et al. · Journal for ImmunoTherapy of Cancer · 2016 · 212 citations · Full text

, , +17

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

Richard Aplenc, Susan M. Blaney, Lewis C. Strauss et al. · Journal of Clinical Oncology · 2011 · 124 citations · Full text

, , +16

Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure

Yan Xu, Shruti Agrawal, Thomas J. Cook et al. · Archives of Toxicology · 2006 · 99 citations

, , +15

1–5 of 10